{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-009103","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.314875+00:00","generated_at":"2026-05-16T13:20:40.088486+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Sunshine Biopharma shareholders elect all five directors and approve equity plan increase at annual meeting","bullets":["All five director nominees elected: Dr. Slilaty, Sebaaly, Kiderchah, Natan, Keller received over 130M votes for.","Ratification of M&K CPAS as independent auditor for 2025 approved with 132M for, 178K against.","Amendment to 2023 Equity Incentive Plan to increase authorized shares to 683,000 approved with 130M for, 294K against.","Broker non-votes: 1.77M on director elections and equity plan; 0 on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-009103","json":"https://secwatch.observer/filing/0001683168-25-009103.json","markdown":"https://secwatch.observer/filing/0001683168-25-009103.md","text":"https://secwatch.observer/filing/0001683168-25-009103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/0001683168-25-009103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:20:40.088486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}